Skip to content
10-Q

Quarterly Report

HTG Molecular Diagnostics, Inc.

0000950170-23-020725

← back to feed
Filed
May 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 5, 2023 2.21M sh
Shares Diluted Q1 2023 · Mar 31, 2023 2.21M sh
Shares Diluted Q1 2023 · Mar 31, 2022 667.65K sh
Capex Q1 2023 · Mar 31, 2023 $6.24K
Capex Q1 2023 · Mar 31, 2022 $8.42K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$4.36M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$5.94M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $3M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $12.21M
Stockholders Equity Q1 2023 · Mar 31, 2023 $474.5K
Stockholders Equity Q1 2023 · Dec 31, 2022 $5.39M
Stockholders Equity Q1 2023 · Mar 31, 2022 $11.27M
Stockholders Equity Q1 2023 · Dec 31, 2021 $10.4M
Current Liabilities Q1 2023 · Mar 31, 2023 $6.56M
Current Liabilities Q1 2023 · Dec 31, 2022 $8.27M
Total Liabilities Q1 2023 · Mar 31, 2023 $10.39M
Total Liabilities Q1 2023 · Dec 31, 2022 $12.39M
Current Assets Q1 2023 · Mar 31, 2023 $9.19M
Current Assets Q1 2023 · Dec 31, 2022 $15.65M
Total Assets Q1 2023 · Mar 31, 2023 $10.87M
Total Assets Q1 2023 · Dec 31, 2022 $17.78M
Eps Diluted Q1 2023 · Mar 31, 2023 −$2.28
Eps Diluted Q1 2023 · Mar 31, 2022 −$9.73
Eps Basic Q1 2023 · Mar 31, 2023 −$2.28
Eps Basic Q1 2023 · Mar 31, 2022 −$9.73
Sga Expense Q1 2023 · Mar 31, 2023 $3.28M
Sga Expense Q1 2023 · Mar 31, 2022 $4.66M
Rd Expense Q1 2023 · Mar 31, 2023 $1.61M
Rd Expense Q1 2023 · Mar 31, 2022 $1.92M
Net Income Q1 2023 · Mar 31, 2023 −$5.05M
Net Income Q1 2023 · Mar 31, 2022 −$6.5M
Operating Income Q1 2023 · Mar 31, 2023 −$5.01M
Operating Income Q1 2023 · Mar 31, 2022 −$6.25M
Revenue Q1 2023 · Mar 31, 2023 $1.03M
Revenue Q1 2023 · Mar 31, 2022 $1.18M